Indications of colistin treatment (%)] | |
● Culture-proven infection | 36 (87.8%) |
● Empirically | 5 (12.2%) |
Causative microorganism [number (%)] | |
● A. baumannii | 20 (48.8%) |
● P. aeruginosa | 9 (22.0%) |
● A. baumannii and P. aeruginosa | 7 (17.1%) |
● No microorganism | 5 (12.2%) |
Isolation sites of the microorganisms | |
● Tracheal aspirate fluid | 24 (58.5%) |
● Blood or central venous catheter tip | 19 (46.3%) |
● Skin swabs, conjunctival swabs | 4 (9.8%) |
● Cerebrospinal fluid | 2 (4.9%) |
Concomitant antimicrobial agent effective against gram negatives used with colistin [number (%)] | |
● Carbapenems | 22 (53.7%) |
● Aminoglycosides | 14 (34.1%) |
● Piperacillin-tazobactam | 5 (12.2%) |
● Cefoperazone-sulbactam | 1 (2.4%) |